Revolutionary Science Meets Transformative Cancer Therapy
Seattle Genetics is dedicated to improving patient outcomes with transformative therapies targeting cancer
From Promise to Therapy
Seattle Genetics is conducting clinical trials in these and other therapeutic areas:
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Urothelial cancer
- Breast cancer
Join The Seattle Genetics Team
We are a group of passionate innovators dedicated to positively impacting the lives of those living with cancer, and we're always looking to add to our team.
Recent News
Seattle Genetics At A Glance
| Year founded | 1998 |
|
| Global Headquarters | Bothell, WA |
|
| Nasdaq | SGEN |
|
| Number of Employees | ~1,200 |
|
| Clinical & preclinical pipeline programs | 12+ |
|
| ADCs in clinical trials using our technology | 20+ |
|
-
Hear SGEN management present at the Goldman Sachs 39th Annual Global Healthcare Conference at 1:20pm PT ow.ly/Ek7530km3kO · 1 week ago
-
We've announced initiation of a phase 2 trial for women with recurrent or metastatic cervical cancer: ow.ly/rLSl30ktCb0 SGEN · 1 week ago
-
SGEN management will present at the Goldman Sachs 39th Annual Global Healthcare Conference on Wednesday, June 13,… twitter.com/i/web/status/1… · 2 weeks ago
